The most common subtype of lung cancer is non-small cell lung cancer (NSCLC), which has a poor prognosis and seriously threatens the health of human beings. The multidisciplinary comprehensive treatment model has gradually become the mainstream of NSCLC treatment. Traditional Chinese medicine (TCM) can be used effectively either as an adjunctive therapy or alone throughout the NSCLC therapy, which has a significant impact on survival, quality of life, and reduction of toxicity. Therefore, this paper reviewed the theoretical basis, the latest clinical application, and combined treatment mechanisms in order to explore the advantage stage of TCM treatment and the synergistic therapeutic mechanisms.
关键词:
优势阶段;临床应用;机制;非小细胞肺癌;协同治疗;治疗模式;理论基础;中医药;治疗模式
Keywords:
Project Supported:
This work was supported by National Administration of Traditional Chinese Medicine: The Seventh Batch of National Traditional Chinese Medicine Experts Academic Experience Inheritance Project; Tianjin Municipal Education Commission Scientific Research Plan Project (No. 2021KJ143).
Fanming Kong a, b,, Chaoran Wang a, b,c,, Linlin Zhao a, b, Dongying Liao a, b,c, Xiaoqun Wang a, b, Binxu Sun a, b, Peiying Yang a, b, Yingjie Jia a, b,*. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms[J]. Chinese Herbal Medicines (CHM),2023,15(4):509-515
